in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—30 July 2013
7:27 AM MDT | July 30, 2013 | Deepti Ramesh
Lonza reports fall in profits, announces restructuring plans Lonza records a 51.2% fall in net profits for the first half of 2013 compared with the first half of 2012, to 41 million Swiss francs ($44 million). Sales for the first half of2013 decreased by 11.2%, to SF1.74 billion. Lonza also announced certain measures to restructure its activities. Lonza says that its board of directors, on 24 July, decided to phase down the company’s microbial biologics plant at Hopkinton, MA, which will lead to about 2/3 of the 300 jobs at the site being cut by the end of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee